Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Pentaborate Pentahydrate in Advanced RCC
NCT05798455Phase 2Not yet recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2023
- Primary completion
- May 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of sodium pentaborate pentahydrate in renal cell carcinoma (RCC), sponsored by Tabriz University of Medical Sciences. Planned start May 2023; status: not yet recruiting.
02
Drugs
sodium pentaborate pentahydrate
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT05798455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05798455.